AMRX - Amneal Pharmaceuticals Inc.

-

$undefined

N/A

(N/A)

Amneal Pharmaceuticals Inc. NEW YORK STOCK EXCHANGE INC.:AMRX Amneal Pharmaceuticals, Inc., headquartered in Bridgewater, NJ, is a fully-integrated pharmaceutical company focused on the development, manufacturing and distribution of generic and specialty drug products. The Company has operations in North America, Asia, and Europe, working together to bring high-quality medicines to patients primarily within the United States.

Location: 400 Crossing Blvd Fl 3, New Jersey, 08807-2863, US | Website: www.amneal.com | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing


Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

5.325B

Cash

47.22M

Avg Qtr Burn

N/A

Short % of Float

3.01%

Insider Ownership

54.46%

Institutional Own.

43.95%

Qtr Updated

06/30/24


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date
PEMRYDI RTU® Details
Small cell lung cancer, Malignant pleural/peritoneal mesothelioma

Approved

Update

Lisdexamfetamine Dimesylate Details
Attention deficit hyperactivity disorder

Approved

Quarterly sales

RELEUKO® (filgrastim-ayow) Details
Chemotherapy-induced neutropenia

Approved

Quarterly sales

Approved

Quarterly sales

Approved

Quarterly sales

Approved

Quarterly sales

Approved

Quarterly sales

BORUZU (Bortezomib) Details
Multiple myeloma, Mantle cell lymphoma

Approved

Quarterly sales